Covidien to acquire VNUS for $440M

Healthcare firm Covidien has inked an agreement to acquire VNUS Medical Technologies of San Jose, CA, for $440 million.

Covidien, based in Dublin, Ireland, will pay $29 in cash per VNUS share for the transaction, which has been approved by both companies' boards of directors. The acquisition is expected to close by the end of June.

VNUS develops medical devices for minimally invasive treatment of venous reflux disease. Covidien plans to make VNUS part of its vascular product line in the Medical Devices segment.

Related Reading

Covidien adds to Q2 sales, May 1, 2009

Covidien, B&W to tackle medical isotope dilemma, January 28, 2009

Covidien to move HQ to Ireland, January 7, 2009

Covidien shows gains in fiscal 2008, November 17, 2008

PETNet, Covidien join forces, November 3, 2008

Copyright © 2009

Page 1 of 3462
Next Page